Lack of pharmacokinetic interaction between nelfinavir and nevirapine. 1998

G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso

UI MeSH Term Description Entries
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019829 Nevirapine A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS. BI-RG-587,Nevirapine Hemihydrate,Viramune,BI RG 587,BIRG587,Hemihydrate, Nevirapine
D019888 Nelfinavir A potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. AG 1343,AG-1343,AG1343,Nelfinavir Mesylate,Nelfinavir Monomethane Sulfonate,Viracept,Mesylate, Nelfinavir,Monomethane Sulfonate, Nelfinavir,Sulfonate, Nelfinavir Monomethane

Related Publications

G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
December 1998, AIDS (London, England),
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
October 2005, Antimicrobial agents and chemotherapy,
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
January 1998, Journal of the American Pharmaceutical Association (Washington, D.C. : 1996),
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
May 2007, European journal of clinical pharmacology,
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
July 2005, Anti-cancer drugs,
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
December 2014, Antimicrobial agents and chemotherapy,
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
January 1998, Antiviral therapy,
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
February 1998, The New England journal of medicine,
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
January 2000, Journal of clinical pharmacology,
G Skowron, and G Leoung, and B Kerr, and A Dusek, and R Anderson, and S Beebe, and R Grosso
August 1994, British journal of clinical pharmacology,
Copied contents to your clipboard!